SGLT2 inhibitors use not tied to significant risk of amputations in diabetics: Study
Singapore: A meta-analysis of 15 randomized controlled trials of SGLT2 inhibitors for diabetes and non-diabetes patients, showed no significant difference in amputation risk for the various SGLT2...
National University Of Singapore Singapore General Canagliflozin Cardiovascular Assessment Study National University Sodium Glucose Cotransporter Amputation Events
Source: medicaldialogues.in